AI Science Tracker

Shanghai MetaNovas Biotech

1 discovery from 2024

Discoveries

Deep learning designs selective antimicrobial peptides against Cutibacterium acnes

A deep-learning design pipeline combining sequence generation and classifiers, transfer learning, pretrained protein embeddings and C. acnes-specific training data produced 42 novel peptides for testing. Five showed high-potency, selective activity against C. acnes, with MICs of 2–4 µg/mL; additional in-vitro assays tested activity against other microbes, hemolysis and keratinocyte cytotoxicity.

Technology: Deep-learning peptide generators and activity/selectivity classifiers using transfer learning and pretrained protein embeddings

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: A deep-learning design pipeline combining sequence generation and classifiers, transfer learning, pretrained protein embeddings and C. acnes-specific training data produced 42 novel peptides for testing.
  • Still unknown: All evidence is in vitro, with no animal or human testing. The 42 synthesized candidates are a selected subset of model output, and the abstract's five high-potency peptides have measured C. acnes MICs; activity against other organisms and toxicity is based on separate in-vitro assays. Do not imply topical efficacy or clinical safety.
  • AI role: The models generated peptide sequences, ranked antimicrobial/hemolytic properties and incorporated C. acnes-focused training data. The team synthesized and tested 42 selected designs; five had reported C. acnes MICs of 2–4 µg/mL.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10894229/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 22 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.